These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 33956087)
1. The long-term use of tocilizumab in giant cell arteritis. Coath FL; Mukhtyar C Rheumatology (Oxford); 2021 Oct; 60(10):4447-4449. PubMed ID: 33956087 [No Abstract] [Full Text] [Related]
2. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?]. Samson M; Bonnotte B Rev Med Interne; 2018 Feb; 39(2):75-77. PubMed ID: 29217104 [No Abstract] [Full Text] [Related]
3. Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study. Nannini C; Niccoli L; Sestini S; Laghai I; Coppola A; Cantini F Ann Rheum Dis; 2019 Oct; 78(10):1444-1446. PubMed ID: 31213436 [No Abstract] [Full Text] [Related]
12. [Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients]. Broner J; Arnaud E Rev Med Interne; 2018 Feb; 39(2):78-83. PubMed ID: 29221884 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive treatment for giant cell arteritis: where do we stand? Pipitone N; Salvarani C Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-5-6. PubMed ID: 26016749 [No Abstract] [Full Text] [Related]
16. Giant cell arteritis: An updated review of an old disease. Rinden T; Miller E; Nasr R Cleve Clin J Med; 2019 Jul; 86(7):465-472. PubMed ID: 31291180 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of giant cell arteritis patients treated with tocilizumab in a single neuro-ophthalmology practice. Fong JW; Sharieff JA; Patel AD Can J Ophthalmol; 2023 Apr; 58(2):e61-e62. PubMed ID: 36126697 [No Abstract] [Full Text] [Related]
18. Tocilizumab for Giant Cell Arteritis-A New Giant Step in an Old Disease. Tamaki H; Hajj-Ali RA JAMA Neurol; 2018 Feb; 75(2):145-146. PubMed ID: 29255889 [No Abstract] [Full Text] [Related]
19. Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis? Gordon LK; Sadun AA; Van Stavern G; Lee AG J Neuroophthalmol; 2022 Jun; 42(2):e535-e536. PubMed ID: 35594160 [No Abstract] [Full Text] [Related]
20. Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis. Tomelleri A; Rinaldi E; Campochiaro C; Picchio M; Dagna L Rheumatology (Oxford); 2023 Feb; 62(2):e24-e26. PubMed ID: 35861513 [No Abstract] [Full Text] [Related] [Next] [New Search]